Designed for CAR-NK Cell Manufacturing. Proven by Data. Trusted for Results.
Download our white paper to explore how PBS Biotech, GeneFab, and Repligen enable scalable, high-yield CAR-NK cell expansion with integrated perfusion technology
Unlock High-Yield, Clinically Relevant CAR-NK Cell Expansion
- Strategies for NK cell expansion and scale-up using VWBs at 100mL and 3L volumes
- The use of Alternating Tangential Flow-2 (ATF2) technology for integrated perfusion to optimize medium exchange
- Achieving clinically relevant yields of high-potency CAR-NK cells through scalable, contamination-minimizing processes
With innovative bioreactor design and process integration, this study supports robust, scalable manufacturing of next-generation CAR-NK cell therapies